The document discusses several phakomatoses, which are a group of disorders involving structures derived from neuroectoderm that commonly exhibit pathology in tissues from other germ layers. It provides details on Sturge-Weber syndrome, tuberous sclerosis, neurofibromatosis types 1 and 2, and several other less common phakomatoses. For each, it describes clinical presentation, characteristic neuroimaging findings on CT and MRI, and involvement of other organ systems.
3. ο
ο Definition
ο The term β Phakomaβand its Embryological
Connection
ο Clinical Presentation
ο Neuroradiological Presentation
ο Cases
Learning Goals
4. ο
ο The phakomatoses are a heterogeneous group of
disorders primarily involving structures derived
from the embryologic neuroectoderm.
ο However, they commonly exhibit associated
pathology in tissues derived from all three germ cell
layers, most notably ectoderm (skin) and mesoderm
(connective tissue).
Definition
5. ο
ο All the phakomatoses involve the central nervous
system (CNS); some also affect the peripheral
nervous system. Most are associated with cutaneous
signs, and many have visceral and connective tissue
(mesodermal) changes.
ο Since the eye is functionally and developmentally
part of the CNS, it is not surprising that
ocular/retinal involvement is common in the
phakomatoses.
6. ο
ο The term "phakoma" implies a benign growth of
normal or nearly normal cells that are indigenous to
the involved tissue; it may be likened to the term
"hamartoma."
ο The word phakoma is usually described as being
derived from the Greek "phakos"- a word whose
meaning is erroneously generalized to include
"mother spot" (birthmark?) and "lentil," as well as its
true meaning which is "lens" or "eye
Phakoma
7. ο
ο In 1920, the Dutch ophthalmologist van der Hoeve
first used "phakoma" to describe two different
benign ocular lesions.
ο Neurofibromatosis (NF)
ο Tuberous sclerosis (TS)
ο Calling both these lesions "phakomas," van der
Hoeve then assumed that TS and NF were related
diseases, and
8. ο
ο coined the term "phakomatoses" as the umbrella for
congenital disorders affecting the CNS with benign
growths.
ο Later, he enlarged this concept to include other
conditions characterized by CNS, cutaneous, and
often ocular involvement, eg, Sturge-Weber
syndrome (SWS) and von Hippel-Lindau disease.
9. ο
ο Although authorities debate the logic of this
grouping, some 20 to 30 other disorders have now
been classified as phakomatoses
11. ο
ο Sturge-Weber syndrome (SWS) is a congenital
disorder of the vasculature of the face, the meninges,
the brain, and often the eye.
ο It is sometimes called "encephalofacial" or
"encephalotrigeminal" angiomatosis, because the
hallmark is the vascular lesion that involves the
territory of the trigeminal nerve (CN V) plus the
ipsilateral brain and meninges.
12. ο
ο Typical patients exhibit a dark red or reddish-brown
"port-wine" stain or nevus ("nevus flammeus") on the
face in the trigeminal territory
ο The most common clinical manifestation is with
childhood seizures, present in 71-89% of cases 2, that
are often refractory to medical therapy 1. These
usually begin in the first few years of life and are
often associated with developmental delay and
hemispheric symptoms including
hemiplegia/hemiparesis and hemianopsia.
Clinical Pres
13. ο
Neuroradiology
CT
ο detects subcortical calcification at an earlier age than
plain film and can also demonstrate associated
parenchymal volume loss
ο tram-track sign of cortical and subcortical
calcification
16. ο
ο Prominent leptomeningeal enhancement in affected
area
ο Much later in life the angioma may 'burn out' losing
enhancement
ο Enlarged ipsilateral choroid plexus
MRI
19. ο
ο Tuberous sclerosis (TS), also known as tuberous
sclerosis complex or Bourneville disease, is a
neurocutaneous disorder (phakomatosis)
characterised by the development of multiple benign
tumours of the embryonic ectoderm (e.g. skin, eyes,
and nervous system).
Definition
20. ο
Tuberous sclerosis was classically described as
presenting in childhood with a triad (Vogt triad) of:
ο seizures: absent in one-quarter of individuals
ο mental retardation: up to half have normal
intelligence
ο adenoma sebaceum: only present in about three-
quarters of patients
Clinical Triad
21. ο
Tuberous sclerosis has a significant number of
manifestations, involving many organ systems. The
most common manifestations are:
ο cortical or subependymal tubers and white matter
abnormalities
ο renal angiomyolipomas (AML)
ο cardiac rhabdomyoma(s)
22. ο
ο cortical/subcortical tubers: 50% are in the frontal lobe;
high T2 and low T1 with only 10% of tubers showing
enhancement; frequently calcify after two years of age
ο subependymal hamartomas
ο 88% are associated with calcification, although calcification
absent in early childhood
ο visible within the first six months of age
ο variable signal, frequently high T1 and iso to high T2
ο enhancement is variable and is not a useful feature in
distinguishing them from subependymal giant cell
astrocytomas (SGCA); only serial growth is reliable 5,6
Neurological
23. ο
ο subependymal giant cell astrocytomas (SGCA)
ο peak occurrence 8-18 years
ο tend to be large and demonstrate growth 5,6
ο tend to have intense enhancement
ο white matter abnormalities
ο variable appearance, with nodular, ill-defined, cystic
and band-like lesions seen
ο retinal phakomas
24. ο
ο rarer findings
ο cerebellar atrophy
ο infarcts (due to occlusive vascular disorders)
ο cerebral aneurysms
ο dysgenesis of the corpus callosum
ο Chiari malformations
ο microcephaly
ο arachnoid cysts
ο chordoma
28. ο
ο Neurofibromatosis type 1 (NF1), also known as von
Recklinghausen disease, is a multisystem
neurocutaneous disorder, the most
common phakomatosis.
ο Also known as peripheral neurofibromatosis
Neurofibromatosis 1
29. ο
ο >6 cafe au lait spots evident during one year
ο two or more neurofibromas or one plexiform
neurofibroma
ο optic nerve glioma
ο distinctive osseous lesion (such as sphenoid wing
dysplasia or thinning of long bone cortex with or
without pseudoarthrosis)
ο two or more iris hamartomas (Lisch nodules)
ο axillary or inguinal freckling
ο primary relative with NF1 with above criteria
Diagnostic Crit
30. ο
ο Breast manifestations
ο Central nervous system manifestations
ο Cutaneous manifestations
ο Musculoskeletal manifestations
ο Pulmonary manifestations
ο Orbital manifestations
Systemic manifestations
31. ο
ο FASI (focal areas of signal intensity): occur in deep
white matter and basal ganglia or corpus callosum 5,
areas of T2/FLAIR hyperintensity with no contrast
enhancement
ο optic nerve glioma or optic pathway glioma (may
manifest as enlarged optic foramen)
ο progressive sphenoid wing dysplasia
CNS manifestations
38. ο
ο Neurofibromatosis type 2 (NF2) is a rare autosomal
dominant neurocutaneous disorder (phakomatosis)
manifesting as a development of multiple CNS
tumours.
ο Unlike neurofibromatosis type 1 (NF1), it is not
associated with neurofibromas.
ο May be called central neurofibromatosis.
Neurofibromatosis 2
39. ο
Instead, patients with this disease have:
ο intracranial schwannoma(s): mostly vestibular
schwannoma(s) sometimes patients may have spinal
schwannomas
ο intracranial and spinal meningioma(s)
ο intraspinal-intramedullary ependymoma(s)
CNS lesions
40. ο
ο These features give rise to the acronym MISME,
which describes Multiple Inherited Schwannomas
Meningiomas and Ependymomas 4.
ο In fact, labelling this disorder neurofibromatosis
type 2 is a misnomer, because neurofibromas are not
a part of its constellation of abnormalities
MISME
46. ο
ο Bilateral vestibular schwannomas are diagnostic of
NF2 but care should be taken because bilateral
internal acoustic meatus masses are not specific for
vestibular schwannoma and can represent, for
example, sarcoid or metastases .
Practical points
47. ο
ο ataxia telangiectasia
ο von Hippel-Lindau disease (retinocerebellar
angiomatosis)
ο incontinentia pigmenti (Bloch-Sulzberger syndrome)
ο basal cell naevus syndrome (Gorlin-Goltz syndrome)
ο Wyburn-Mason syndrome (Bonnet-Dechaume-Blanc
syndrome)
ο encephalocraniocutaneous lipomatosis
ο hypomelanosis of Ito
Other Phakomatosis